Pharmacists in New Cumberland, Pennsylvania


13 Pharmacists found in New Cumberland
female pharmacist

Amy Elvidge


Pharmacist
130 Old York Rd, New Cumberland, PA 17070
717-909-4320    

male pharmacist

Barry F Barkley Jr., RPH


Pharmacist
130 Old York Rd, New Cumberland, PA 17070
717-909-4320     717-909-4322

male pharmacist

Brandon Regan Anderson, B. PHARM


Pharmacist
105 Old York Rd, New Cumberland, PA 17070
717-774-0261     717-774-2810



female pharmacist

Mrs. Daisy A Sarpong, PHARMD


Pharmacist
560 Old York Rd, New Cumberland, PA 17070
717-932-0226    

male pharmacist

Dhanaraj Kabali, B.S. PHARM MBA


Pharmacist
118 Pin Oak Dr, New Cumberland, PA 17070
717-774-8692     717-774-8693

female pharmacist

Elizabeth Humes Appleby, RPH


Pharmacist
701 Bridge St, New Cumberland, PA 17070
717-774-6262    

female pharmacist

Grace Whalen


Pharmacist
130 Old York Rd, New Cumberland, PA 17070
717-909-4320    

female pharmacist

Linda Valencik


Pharmacist
105 Old York Rd, New Cumberland, PA 17070
717-774-0450    

male pharmacist

Michael Sapmee


Pharmacist
560 Old York Rd, New Cumberland, PA 17070
717-932-0226    

male pharmacist

Mr. Michael Grant Moyer, RPH


Pharmacist
701 Bridge St, New Cumberland, PA 17070
717-774-6262    

female pharmacist

Nicole Werner


Pharmacist
560 Old York Rd, New Cumberland, PA 17070
717-932-0226    

female pharmacist

Dr. Sara Elizabeth Trimmer, PHARMD


Pharmacist
701 Bridge St, New Cumberland, PA 17070
717-774-6262     717-774-8852

male pharmacist

Dr. Zhong De Li, PHARMD


Pharmacist
105 Old York Rd, New Cumberland, PA 17070
717-774-0261    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.